Adenosine

Adenosine at a Glance

Adenosine is not really a plant constituent in the way the rest of this collection is. It is a purine nucleoside — adenine joined to a ribose sugar — and it is a component of every living cell: the backbone of ATP, a building block of RNA, part of the cofactors NAD and coenzyme A. Anything alive contains it. That ubiquity makes “contains adenosine” a nearly empty statement about a herb.

What is not empty is its signalling role. Released into the space between cells when tissue is working hard or short of oxygen, adenosine acts on four G-protein-coupled receptors, A₁, A₂ₐ, A₂_B and A₃, which between them regulate the nervous, cardiovascular and immune systems ^{8Reference 8Borea PA et al. · 2018ReviewPharmacology of adenosine receptors: the state of the art — reviewView study →}. It slows the heart, dilates blood vessels, damps inflammation, and accumulates in the brain across a waking day to produce sleep pressure. Most people meet it indirectly: caffeine works by blocking adenosine receptors, which is why coffee, guarana, yerba mate and cacao belong to adenosine’s story without containing anything much of it.

As a herbal constituent it is worth writing about in exactly one context — the medicinal fungi. There it is a measured, quantified pharmacopoeial marker for cordyceps ^{1,9Reference 1Ikeda R et al. · 2008Simple HPLC-UV determination of nucleosides and its application to the authentication of Cordyceps and its allies — analyticalView study →Reference 9Hu H et al. · 2015Identification of chemical markers in Cordyceps sinensis by HPLC-MS/MS — analyticalView study →}, the component identified behind enoki’s testosterone research ^{2,3Reference 2Iguchi K et al. · 2023AnimalEnokitake mushroom and its active component, adenosine, which restores testosterone production in impaired and fatigued mouse models — mouse in vivoView study →Reference 3Yamada S et al. · 2025RCTBeneficial effects of enoki mushroom extract on male menopausal symptoms in Japanese subjects: a randomized, double-blind, placebo-controlled study — randomised controlled trialView study →}, and the once-proposed explanation for reishi’s antiplatelet reputation, an idea that the only human test of it did not support ^{4,5Reference 4Tao J · 1990Clinical trialExperimental and clinical studies on inhibitory effect of Ganoderma lucidum on platelet aggregation — clinical trialView study →Reference 5Gau JP et al. · 1990Clinical trialThe lack of antiplatelet effect of crude extracts from Ganoderma lucidum on HIV-positive hemophiliacs — in patientsView study →}.

Why “Contains Adenosine” Is Usually Meaningless

Adenosine is in every cell of every organism. A herb contains it, a vegetable contains it, and so does the person taking them. So a constituent list naming adenosine tells a reader almost nothing on its own, and three questions have to be answered before it means anything.

How much? Only quantified sources are informative. Cordyceps material has been measured at 0.28–14.15 mg/g — a fifty-fold range across samples, which is itself the useful fact ^{1Reference 1Ikeda R et al. · 2008Simple HPLC-UV determination of nucleosides and its application to the authentication of Cordyceps and its allies — analyticalView study →}.

Does it survive? Adenosine taken by mouth is a poor way to raise adenosine. It is taken up avidly by red blood cells and rapidly deaminated, so its half-life in blood is measured in seconds — which is precisely why the hospital drug is given as a fast bolus into a vein and not as a tablet ^{7Reference 7McIntosh-Yellin NL et al. · 1993RCTSafety and efficacy of central intravenous bolus administration of adenosine for termination of supraventricular tachycardia — randomised controlled trialView study →}.

Is it doing the work? Because adenosine is present everywhere, attributing a herb’s effect to it requires showing the effect tracks the adenosine and not something else. The fungal literature below contains one case where that was done properly, and one where it was assumed and then contradicted.

Adenosine & Caffeine

The commonest way anyone encounters adenosine is by blocking it. Caffeine is an adenosine-receptor antagonist, principally at A₁ and A₂ₐ, and theobromine in cacao acts on the same receptors more weakly. Adenosine accumulating through the waking day increases sleep pressure and reduces neuronal firing; caffeine occupies the receptors without activating them, so the accumulated signal goes unread and alertness is preserved.

This is worth stating plainly on an adenosine page because it inverts what a reader might expect from a constituent list. A coffee bean, a guarana seed, a mate leaf and a cacao pod are all significant to adenosine pharmacology — not as sources of it, but as sources of its antagonists. Their pages belong to caffeine and theobromine.

Adenosine in the Medicinal Fungi

Three fungi have a genuine adenosine story, and they are different in kind.

Cordyceps — a quality marker. Adenosine is used analytically to authenticate cordyceps and grade its quality. An HPLC method quantifying five nucleosides across Cordyceps material and its lookalikes found adenosine at 0.28–14.15 mg/g and cordycepin at 0.006–6.36 mg/g, with cordycepin characteristic of C. militaris; the authors proposed the ratio of the other nucleosides to adenosine as the authentication marker rather than any single figure ^{1Reference 1Ikeda R et al. · 2008Simple HPLC-UV determination of nucleosides and its application to the authentication of Cordyceps and its allies — analyticalView study →}. Chemical-marker work on C. sinensis supports the same approach ^{9Reference 9Hu H et al. · 2015Identification of chemical markers in Cordyceps sinensis by HPLC-MS/MS — analyticalView study →}. This is real and useful — and it is analytical chemistry, not pharmacology. Adenosine identifies cordyceps; it is not what cordyceps is taken for.

Enoki — the properly demonstrated case. Extracts of enoki (Flammulina velutipes) raised testosterone production in cisplatin-impaired and fatigue mouse models, and liquid chromatography–mass spectrometry identified adenosine as the component chiefly responsible, acting on Leydig-cell function through insulin-like peptide 3; structurally related compounds including cordycepin were less active ^{2Reference 2Iguchi K et al. · 2023AnimalEnokitake mushroom and its active component, adenosine, which restores testosterone production in impaired and fatigued mouse models — mouse in vivoView study →}. A 12-week randomised, double-blind, placebo-controlled trial of a powdered enoki extract containing adenosine in middle-aged and elderly Japanese men then found a significant improvement in the sexual subscale of the Aging Males’ Symptoms score, with significantly more high-responders than placebo ^{3Reference 3Yamada S et al. · 2025RCTBeneficial effects of enoki mushroom extract on male menopausal symptoms in Japanese subjects: a randomized, double-blind, placebo-controlled study — randomised controlled trialView study →}. That is an unusually complete chain for a fungal constituent — mechanism, animal model, compound identification and a human trial — though the trial tested a proprietary extract rather than adenosine.

Reishi — the claim that did not hold. Reishi’s antiplatelet reputation is long-standing, and adenosine has often been named as its basis. The evidence does not support that attribution. The clinical study usually cited found that a water-soluble reishi extract inhibited platelet aggregation in healthy volunteers in vitro and reduced ADP-induced aggregation after two weeks of oral dosing in patients with atherosclerotic disease — but its authors concluded explicitly that the mechanism and active principles remained to be investigated ^{4Reference 4Tao J · 1990Clinical trialExperimental and clinical studies on inhibitory effect of Ganoderma lucidum on platelet aggregation — clinical trialView study →}. A platelet-aggregation inhibitor was separately isolated from G. lucidum in 1985 ^{6Reference 6Shimizu A et al. · 1985In vitroIsolation of an inhibitor of platelet aggregation from a fungus, Ganoderma lucidum — in vitroView study →}.

Then the adenosine hypothesis was tested directly, and failed. Researchers gave five haemophilia A patients a reishi extract analysed at 150 mg adenosine per 100 g, delivering an estimated 1.35 mg of adenosine daily, specifically because the extract’s high adenosine content raised concern about an unwanted antiplatelet effect. Platelet aggregation tests before and after showed no significant change, and the authors concluded the extract had no antiplatelet effect in vivo despite its adenosine content ^{5Reference 5Gau JP et al. · 1990Clinical trialThe lack of antiplatelet effect of crude extracts from Ganoderma lucidum on HIV-positive hemophiliacs — in patientsView study →}. The bleeding-risk caution attached to reishi may still be reasonable on other grounds, but “because of its adenosine” is not one of them.

Its Established Human Use

Adenosine is a hospital drug, and its use has nothing to do with herbs. Injected rapidly into a vein it blocks conduction through the atrioventricular node for a few seconds, which terminates most re-entrant supraventricular tachycardias.

The dosing reflects its extraordinary lability. In a study where thirty adults received adenosine by both routes in randomised order, escalating in 3, 6, 9 and 12 mg increments, central administration terminated 77% of episodes at 3 mg against 37% peripherally, with no difference in side effects, and the recommended initial central dose was set at 3 mg ^{7Reference 7McIntosh-Yellin NL et al. · 1993RCTSafety and efficacy of central intravenous bolus administration of adenosine for termination of supraventricular tachycardia — randomised controlled trialView study →}. Peripheral dosing needs more because much of the drug is destroyed on the way. Related vasodilator protocols use adenosine to stress the heart for myocardial perfusion imaging.

This route makes the herbal point by contrast: a molecule that has to be pushed into a central vein to reach its target in useful quantity is not one an oral mushroom extract delivers systemically.

What It's Used For

The applications below are separated by what actually generated the evidence — an injected drug, a mushroom trial, or an assumption.

Evidence by IndicationStrength of support · Beta

01Supraventricular Tachycardia (Intravenous)Proven80%Established emergency drug; randomised route-comparison dosing study ^{7Reference 7McIntosh-Yellin NL et al. · 1993RCTSafety and efficacy of central intravenous bolus administration of adenosine for termination of supraventricular tachycardia — randomised controlled trialView study →}

02Cordyceps Quality MarkerPromising50%Validated HPLC quantification and authentication method — analytical, not therapeutic ^{1,9Reference 1Ikeda R et al. · 2008Simple HPLC-UV determination of nucleosides and its application to the authentication of Cordyceps and its allies — analyticalView study →Reference 9Hu H et al. · 2015Identification of chemical markers in Cordyceps sinensis by HPLC-MS/MS — analyticalView study →}

03Testosterone & Male Ageing (Enoki)Shaky40%Mouse models with compound identification plus one 12-week RCT of a proprietary extract ^{2,3Reference 2Iguchi K et al. · 2023AnimalEnokitake mushroom and its active component, adenosine, which restores testosterone production in impaired and fatigued mouse models — mouse in vivoView study →Reference 3Yamada S et al. · 2025RCTBeneficial effects of enoki mushroom extract on male menopausal symptoms in Japanese subjects: a randomized, double-blind, placebo-controlled study — randomised controlled trialView study →}

04Antiplatelet Activity (Reishi)Shaky14%Attribution contradicted by the one human test of it ^{4,5Reference 4Tao J · 1990Clinical trialExperimental and clinical studies on inhibitory effect of Ganoderma lucidum on platelet aggregation — clinical trialView study →Reference 5Gau JP et al. · 1990Clinical trialThe lack of antiplatelet effect of crude extracts from Ganoderma lucidum on HIV-positive hemophiliacs — in patientsView study →}

Mechanisms

The receptor rows are real and important physiology; the herbal rows are, with one exception, about measurement rather than effect.

Pharmacokinetics

Adenosine has one of the shortest durations of action in clinical medicine. Circulating adenosine is taken up rapidly by erythrocytes and endothelial cells through nucleoside transporters and deaminated by adenosine deaminase, giving a plasma half-life on the order of seconds. That is the reason the intravenous drug is delivered as a fast bolus followed by a saline flush, and the reason central administration is more efficient than peripheral — less of the dose is destroyed en route ^{7Reference 7McIntosh-Yellin NL et al. · 1993RCTSafety and efficacy of central intravenous bolus administration of adenosine for termination of supraventricular tachycardia — randomised controlled trialView study →}.

For a herbal page the implication is decisive. Oral adenosine faces gut and hepatic metabolism on top of that, and no oral preparation has been shown to raise systemic adenosine meaningfully. Where an adenosine-containing mushroom extract has a demonstrated effect, as in the enoki testosterone work, the plausible route is local action in the gut or on tissue rather than a systemic rise in adenosine — and that has not been resolved ^{2,3Reference 2Iguchi K et al. · 2023AnimalEnokitake mushroom and its active component, adenosine, which restores testosterone production in impaired and fatigued mouse models — mouse in vivoView study →Reference 3Yamada S et al. · 2025RCTBeneficial effects of enoki mushroom extract on male menopausal symptoms in Japanese subjects: a randomized, double-blind, placebo-controlled study — randomised controlled trialView study →}.

Clinical Trials

Human evidence divides sharply by route. Intravenous adenosine is an established drug with a large clinical literature and settled dosing ^{7Reference 7McIntosh-Yellin NL et al. · 1993RCTSafety and efficacy of central intravenous bolus administration of adenosine for termination of supraventricular tachycardia — randomised controlled trialView study →}. Oral human evidence relating to adenosine as a constituent is limited to the enoki extract trial ^{3Reference 3Yamada S et al. · 2025RCTBeneficial effects of enoki mushroom extract on male menopausal symptoms in Japanese subjects: a randomized, double-blind, placebo-controlled study — randomised controlled trialView study →} and the reishi work, in which the adenosine hypothesis was not supported ^{5Reference 5Gau JP et al. · 1990Clinical trialThe lack of antiplatelet effect of crude extracts from Ganoderma lucidum on HIV-positive hemophiliacs — in patientsView study →}.

Last checked: September 2026.

Isolate vs. Plant Studies

The isolate is a licensed drug and the plant material is a food, and almost nothing carries between them, because of the route. The clinical evidence for the isolate is intravenous; the fungal evidence is oral; and adenosine’s seconds-long plasma survival means the second cannot reproduce the first.

The one place the two nearly meet is enoki, where the compound was identified by mass spectrometry in the active extract ^{2Reference 2Iguchi K et al. · 2023AnimalEnokitake mushroom and its active component, adenosine, which restores testosterone production in impaired and fatigued mouse models — mouse in vivoView study →} and an extract containing it then worked in a randomised trial ^{3Reference 3Yamada S et al. · 2025RCTBeneficial effects of enoki mushroom extract on male menopausal symptoms in Japanese subjects: a randomized, double-blind, placebo-controlled study — randomised controlled trialView study →} — but even there the human study tested the extract, so the causal step is carried by the mouse work.

The reishi case is the cautionary one, and worth generalising. A herb was known to have an effect, a ubiquitous constituent was proposed as the explanation because it has a matching pharmacology in another setting, and when the hypothesis was finally tested in people it did not hold ^{4,5Reference 4Tao J · 1990Clinical trialExperimental and clinical studies on inhibitory effect of Ganoderma lucidum on platelet aggregation — clinical trialView study →Reference 5Gau JP et al. · 1990Clinical trialThe lack of antiplatelet effect of crude extracts from Ganoderma lucidum on HIV-positive hemophiliacs — in patientsView study →}. Constituent-level explanations are cheap, and adenosine, being in everything, is available as an explanation for almost anything.

Its Role in Living Things

Adenosine is not a secondary metabolite at all — it is primary metabolism. As part of ATP it is the currency of cellular energy; as part of RNA it is one of the four bases; and it is built into NAD, FAD and coenzyme A, the cofactors of central metabolism. Its release into extracellular space is a signal of metabolic stress: when a tissue works hard, runs short of oxygen or breaks down ATP faster than it regenerates it, adenosine escapes and acts locally, dilating vessels to bring more blood and damping the activity that caused the deficit ^{8Reference 8Borea PA et al. · 2018ReviewPharmacology of adenosine receptors: the state of the art — reviewView study →}.

In fungi it accumulates as part of the nucleotide pool, and the fruiting bodies of some species carry enough to be measurable and useful analytically ^{1Reference 1Ikeda R et al. · 2008Simple HPLC-UV determination of nucleosides and its application to the authentication of Cordyceps and its allies — analyticalView study →}. That is metabolism, not defence chemistry, and it is the reason fungal adenosine content varies so widely with strain, substrate and developmental stage.

Prevalence in Nature

Universal. Adenosine occurs in every organism as a component of ATP, RNA and the major cofactors, so its presence in a plant or fungus is guaranteed and uninformative on its own.

What is informative is the measured amount. In cordyceps, adenosine has been quantified at 0.28–14.15 mg/g across material and its allies, a fifty-fold spread, alongside guanosine at 0.68–14.79 and uridine at 0.19–20.29 mg/g ^{1Reference 1Ikeda R et al. · 2008Simple HPLC-UV determination of nucleosides and its application to the authentication of Cordyceps and its allies — analyticalView study →}. Enoki is described as relatively adenosine-rich, which is the premise of its testosterone research ^{2Reference 2Iguchi K et al. · 2023AnimalEnokitake mushroom and its active component, adenosine, which restores testosterone production in impaired and fatigued mouse models — mouse in vivoView study →}. Reishi extract has been analysed at 150 mg per 100 g — 1.5 mg/g ^{5Reference 5Gau JP et al. · 1990Clinical trialThe lack of antiplatelet effect of crude extracts from Ganoderma lucidum on HIV-positive hemophiliacs — in patientsView study →}. Vegetables and other mushrooms carry it in comparable small amounts ^{2Reference 2Iguchi K et al. · 2023AnimalEnokitake mushroom and its active component, adenosine, which restores testosterone production in impaired and fatigued mouse models — mouse in vivoView study →}.

Adenosine more often appears as the thing something else acts on: caffeine in coffee, guarana, yerba mate and guayusa, and theobromine in cacao, are adenosine-receptor antagonists, and linalool has been reported to act partly through adenosine A₁ and A₂ₐ signalling.

Discovery & Synthesis

Adenosine was identified as a constituent of nucleic acids in the early twentieth century, and its pharmacology arrived separately: the observation in 1929 that an extract containing adenine compounds slowed the heart and dilated coronary vessels was made long before anyone knew why. The four adenosine receptors were characterised much later, and their cloning and classification into A₁, A₂ₐ, A₂_B and A₃ underpins the modern pharmacology ^{8Reference 8Borea PA et al. · 2018ReviewPharmacology of adenosine receptors: the state of the art — reviewView study →}.

There is no botanical production. Adenosine for pharmaceutical and research use is made by fermentation or chemical synthesis, and its derivatives are an active area of drug development — receptor-selective agonists and antagonists are pursued for pain, inflammation, cancer and neurodegenerative disease ^{8Reference 8Borea PA et al. · 2018ReviewPharmacology of adenosine receptors: the state of the art — reviewView study →}. In herbal medicine adenosine is a compound to be measured, not manufactured.

Toxicity & Safety

Adenosine carries a low flag. It is an endogenous molecule present in every cell, destroyed within seconds in the bloodstream, and eaten daily in every food that was ever alive; oral exposure from a mushroom extract is a few milligrams at most and raises no toxicological question.

The adverse effects associated with the name belong to the intravenous drug, not the constituent. A rapid bolus commonly causes transient flushing, chest discomfort, breathlessness and a brief pause in the heartbeat as conduction is blocked — expected, self-limiting within seconds, and the reason it is given under cardiac monitoring. Its effect is potentiated by dipyridamole, which blocks adenosine reuptake, and antagonised by methylxanthines including caffeine and theophylline, which occupy the same receptors; those interactions are managed in clinical practice and have no herbal counterpart at dietary doses.

One point is worth stating plainly: a bleeding-risk caution does not follow from a fungal product’s adenosine content. The only human test of that idea, in patients with haemophilia A, found no effect on platelet aggregation ^{5Reference 5Gau JP et al. · 1990Clinical trialThe lack of antiplatelet effect of crude extracts from Ganoderma lucidum on HIV-positive hemophiliacs — in patientsView study →}. Where a whole-extract bleeding caution is warranted it rests on the extract’s own data.

Safety at a Glance

✅ Low / no toxicity

• Endogenous and ubiquitous. Present in every cell as part of ATP and RNA; oral exposure from herbal material is a few milligrams and raises no toxicological concern.
• Cleared within seconds from blood by red-cell uptake and adenosine deaminase, which limits any systemic effect of an oral dose.
• The known adverse effects are the intravenous drug’s — transient flushing, chest discomfort and a brief cardiac pause under monitoring, not effects of a mushroom.
• Do not infer a bleeding risk from adenosine content. The one human test of that hypothesis, in haemophilia patients, found no change in platelet aggregation.

Dosage

There is no oral dose of adenosine and no purpose in taking one. The figures below are the clinical intravenous doses and the measured content of herbal material. These are doses studied in research and clinical practice, not a personal recommendation.

References

1. Ikeda R, Nishimura M, Sun Y, et al. (2008). Simple HPLC-UV determination of nucleosides and its application to the authentication of Cordyceps and its allies — analytical. Biomed Chromatogr. https://pubmed.ncbi.nlm.nih.gov/18254139/
2. Iguchi K, Nagashima K, Mochizuki J, et al. (2023). Enokitake mushroom and its active component, adenosine, which restores testosterone production in impaired and fatigued mouse models — mouse in vivo. Nutrients. https://pubmed.ncbi.nlm.nih.gov/37432279/
3. Yamada S, Shirai M, Nagashima K, et al. (2025). Beneficial effects of enoki mushroom extract on male menopausal symptoms in Japanese subjects: a randomized, double-blind, placebo-controlled study — randomised controlled trial. Nutrients. https://pubmed.ncbi.nlm.nih.gov/40218966/
4. Tao J, Feng KY (1990). Experimental and clinical studies on inhibitory effect of Ganoderma lucidum on platelet aggregation — clinical trial. J Tongji Med Univ. https://pubmed.ncbi.nlm.nih.gov/2098581/
5. Gau JP, Lin CK, Lee SS, et al. (1990). The lack of antiplatelet effect of crude extracts from Ganoderma lucidum on HIV-positive hemophiliacs — in patients. Am J Chin Med. https://pubmed.ncbi.nlm.nih.gov/2270852/
6. Shimizu A, Yano T, Saito Y, et al. (1985). Isolation of an inhibitor of platelet aggregation from a fungus, Ganoderma lucidum — in vitro. Chem Pharm Bull (Tokyo). https://pubmed.ncbi.nlm.nih.gov/4085058/
7. McIntosh-Yellin NL, Drew BJ, Scheinman MM (1993). Safety and efficacy of central intravenous bolus administration of adenosine for termination of supraventricular tachycardia — randomised controlled trial. J Am Coll Cardiol. https://pubmed.ncbi.nlm.nih.gov/8354807/
8. Borea PA, Gessi S, Merighi S, et al. (2018). Pharmacology of adenosine receptors: the state of the art — review. Physiol Rev. https://pubmed.ncbi.nlm.nih.gov/29848236/
9. Hu H, Xiao L, Zheng B, et al. (2015). Identification of chemical markers in Cordyceps sinensis by HPLC-MS/MS — analytical. Anal Bioanal Chem. https://pubmed.ncbi.nlm.nih.gov/26302964/

View all 9 references▾